Relationship between sustained disability progression and functional system scores in relapsing-remitting multiple sclerosis: Analysis of placebo data from four randomized clinical trials

13Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: The Expanded Disability Status Scale (EDSS), based on different functional system scores (FSS), remains the most frequently used disability assessment in relapsing-remitting multiple sclerosis (RRMS). In this analysis, we evaluated the relationship between sustained disability progression, measured by EDSS, and simultaneous changes in individual FSS domains. Methods: A post hoc analysis was performed on data from placebo-treated RRMS patients from four large, randomized, multicenter, phase 3 clinical trials. Sustained disability progression was defined as a ≥1.0-point EDSS score increase over a ≥3- or ≥6-month period. Simultaneous sustained disability progression and worsening of individual FSS domains was analyzed. Results: The majority of patients experienced sustained disability progression and simultaneous worsening of ≥1 FSS domain, with ≥1-point worsening in the pyramidal domain being most frequently associated with sustained disability progression (in 31-51% of patients), followed by ≥1-point worsening in the cerebellar (35-41% of patients) and sensory (31-45% of patients) domains. Conclusion: The key FSS components correlating with sustained disability progression, measured by EDSS, appear to be pyramidal, cerebellar, and sensory. In this analysis, the simultaneous worsening of consistent FSS domains confirms the validity and reliability of the use of sustained EDSS progression as a measure of disability progression.

Cite

CITATION STYLE

APA

Scott, T., Wang, P., You, X., Mann, M., & Sperling, B. (2015). Relationship between sustained disability progression and functional system scores in relapsing-remitting multiple sclerosis: Analysis of placebo data from four randomized clinical trials. Neuroepidemiology, 44(1), 16–23. https://doi.org/10.1159/000369621

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free